Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Jun 11;93(12):5715–5719. doi: 10.1073/pnas.93.12.5715

Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

P A Claude 1, D R Wotta 1, X H Zhang 1, P L Prather 1, T M McGinn 1, L J Erickson 1, H H Loh 1, P Y Law 1
PMCID: PMC39126  PMID: 8650158

Abstract

The involvement of a conserved serine (Ser196 at the mu-, Ser177 at the delta-, and Ser187 at the kappa-opioid receptor) in receptor activation is demonstrated by site-directed mutagenesis. It was initially observed during our functional screening of a mu/delta-opioid chimeric receptor, mu delta2, that classical opioid antagonists such as naloxone, naltrexone, naltriben, and H-Tyr-Tic[psi,CH2NH]Phe-Phe-OH (TIPPpsi; Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) could inhibit forskolin-stimulated adenylyl cyclase activity in CHO cells stably expressing the chimeric receptor. Antagonists also activated the G protein-coupled inward rectifying potassium channel (GIRK1) in Xenopus oocytes coexpressing the mu delta2 opioid receptor and the GIRK1 channel. By sequence analysis and back mutation, it was determined that the observed antagonist activity was due to the mutation of a conserved serine to leucine in the fourth transmembrane domain (S196L). The importance of this serine was further demonstrated by analogous mutations created in the mu-opioid receptor (MORS196L) and delta-opioid receptor (DORS177L), in which classical opioid antagonists could inhibit forskolin-stimulated adenylyl cyclase activity in CHO cells stably expressing either MORS196L or DORS177L. Again, antagonists could activate the GIRK1 channel coexpressed with either MORS196L or DORS177L in Xenopus oocytes. These data taken together suggest a crucial role for this serine residue in opioid receptor activation.

Full text

PDF
5715

Images in this article

5718Fig. 3
on p.5718

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birnbaum A. K., Wotta D. R., Law P. Y., Wilcox G. L. Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res Mol Brain Res. 1995 Jan;28(1):72–80. doi: 10.1016/0169-328x(94)00185-h. [DOI] [PubMed] [Google Scholar]
  2. Chakrabarti S., Law P. Y., Loh H. H. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. Brain Res Mol Brain Res. 1995 Jun;30(2):269–278. doi: 10.1016/0169-328x(95)00014-j. [DOI] [PubMed] [Google Scholar]
  3. Chakrabarti S., Prather P. L., Yu L., Law P. Y., Loh H. H. Expression of the mu-opioid receptor in CHO cells: ability of mu-opioid ligands to promote alpha-azidoanilido[32P]GTP labeling of multiple G protein alpha subunits. J Neurochem. 1995 Jun;64(6):2534–2543. doi: 10.1046/j.1471-4159.1995.64062534.x. [DOI] [PubMed] [Google Scholar]
  4. Chen C. A., Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques. 1988 Jul-Aug;6(7):632–638. [PubMed] [Google Scholar]
  5. Chen Y., Mestek A., Liu J., Hurley J. A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol. 1993 Jul;44(1):8–12. [PubMed] [Google Scholar]
  6. Dascal N., Schreibmayer W., Lim N. F., Wang W., Chavkin C., DiMagno L., Labarca C., Kieffer B. L., Gaveriaux-Ruff C., Trollinger D. Atrial G protein-activated K+ channel: expression cloning and molecular properties. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10235–10239. doi: 10.1073/pnas.90.21.10235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eason M. G., Kurose H., Holt B. D., Raymond J. R., Liggett S. B. Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J Biol Chem. 1992 Aug 5;267(22):15795–15801. [PubMed] [Google Scholar]
  8. Evans C. J., Keith D. E., Jr, Morrison H., Magendzo K., Edwards R. H. Cloning of a delta opioid receptor by functional expression. Science. 1992 Dec 18;258(5090):1952–1955. doi: 10.1126/science.1335167. [DOI] [PubMed] [Google Scholar]
  9. Fukuda K., Kato S., Mori K. Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem. 1995 Mar 24;270(12):6702–6709. doi: 10.1074/jbc.270.12.6702. [DOI] [PubMed] [Google Scholar]
  10. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 1993 Aug 2;327(3):311–314. doi: 10.1016/0014-5793(93)81011-n. [DOI] [PubMed] [Google Scholar]
  11. Gulya K., Pelton J. T., Hruby V. J., Yamamura H. I. Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sci. 1986 Jun 16;38(24):2221–2229. doi: 10.1016/0024-3205(86)90574-6. [DOI] [PubMed] [Google Scholar]
  12. Henry D. J., Grandy D. K., Lester H. A., Davidson N., Chavkin C. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Mol Pharmacol. 1995 Mar;47(3):551–557. [PubMed] [Google Scholar]
  13. Hescheler J., Rosenthal W., Trautwein W., Schultz G. The GTP-binding protein, Go, regulates neuronal calcium channels. 1987 Jan 29-Feb 4Nature. 325(6103):445–447. doi: 10.1038/325445a0. [DOI] [PubMed] [Google Scholar]
  14. Jin W., Lee N. M., Loh H. H., Thayer S. A. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol. 1992 Dec;42(6):1083–1089. [PubMed] [Google Scholar]
  15. Kieffer B. L., Befort K., Gaveriaux-Ruff C., Hirth C. G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12048–12052. doi: 10.1073/pnas.89.24.12048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kong H., Raynor K., Yasuda K., Moe S. T., Portoghese P. S., Bell G. I., Reisine T. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J Biol Chem. 1993 Nov 5;268(31):23055–23058. [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Law P. Y., Hom D. S., Loh H. H. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol. 1983 Nov;24(3):413–424. [PubMed] [Google Scholar]
  19. Law P. Y., McGinn T. M., Wick M. J., Erikson L. J., Evans C., Loh H. H. Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J Pharmacol Exp Ther. 1994 Dec;271(3):1686–1694. [PubMed] [Google Scholar]
  20. Meng F., Hoversten M. T., Thompson R. C., Taylor L., Watson S. J., Akil H. A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains. J Biol Chem. 1995 May 26;270(21):12730–12736. doi: 10.1074/jbc.270.21.12730. [DOI] [PubMed] [Google Scholar]
  21. Meng F., Xie G. X., Thompson R. C., Mansour A., Goldstein A., Watson S. J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9954–9958. doi: 10.1073/pnas.90.21.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Minami M., Onogi T., Nakagawa T., Katao Y., Aoki Y., Katsumata S., Satoh M. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors. FEBS Lett. 1995 May 1;364(1):23–27. doi: 10.1016/0014-5793(95)00340-f. [DOI] [PubMed] [Google Scholar]
  23. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  24. North R. A., Williams J. T., Surprenant A., Christie M. J. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5487–5491. doi: 10.1073/pnas.84.15.5487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Onogi T., Minami M., Katao Y., Nakagawa T., Aoki Y., Toya T., Katsumata S., Satoh M. DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops. FEBS Lett. 1995 Jan 2;357(1):93–97. doi: 10.1016/0014-5793(94)01341-w. [DOI] [PubMed] [Google Scholar]
  26. Piros E. T., Prather P. L., Loh H. H., Law P. Y., Evans C. J., Hales T. G. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol Pharmacol. 1995 May;47(5):1041–1049. [PubMed] [Google Scholar]
  27. Sharma S. K., Nirenberg M., Klee W. A. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci U S A. 1975 Feb;72(2):590–594. doi: 10.1073/pnas.72.2.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Surratt C. K., Johnson P. S., Moriwaki A., Seidleck B. K., Blaschak C. J., Wang J. B., Uhl G. R. -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem. 1994 Aug 12;269(32):20548–20553. [PubMed] [Google Scholar]
  29. White A. A., Karr D. B. Improved two-step method for the assay of adenylate and guanylate cyclase. Anal Biochem. 1978 Apr;85(2):451–460. doi: 10.1016/0003-2697(78)90242-7. [DOI] [PubMed] [Google Scholar]
  30. Wimpey T. L., Chavkin C. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron. 1991 Feb;6(2):281–289. doi: 10.1016/0896-6273(91)90363-5. [DOI] [PubMed] [Google Scholar]
  31. Xue J. C., Chen C., Zhu J., Kunapuli S. P., de Riel J. K., Yu L., Liu-Chen L. Y. The third extracellular loop of the mu opioid receptor is important for agonist selectivity. J Biol Chem. 1995 Jun 2;270(22):12977–12979. [PubMed] [Google Scholar]
  32. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T., Bell G. I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6736–6740. doi: 10.1073/pnas.90.14.6736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yu V. C., Sadée W. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J Pharmacol Exp Ther. 1988 Apr;245(1):350–355. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES